# Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

Study · id `cardio:ct-nct05162599` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05162599](<https://clinicaltrials.gov/study/NCT05162599>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05162599

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT05162599. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-06-08 (actual); primary completion 2023-06-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT05162599, source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)
- Started: 2022-06-08 (actual) (ClinicalTrials.gov record NCT05162599, source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)
- Primary completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT05162599, source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)
- Completion: 2023-06-08 (actual) (ClinicalTrials.gov record NCT05162599, source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05162599, source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05162599-2024-01-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Cardiags Trimod for Analysis of Cardiac Activity
- Acronym: EVALTRIMOD
- Condition: Murmur, Heart
- Condition: Rhythm; Abnormal
- Intervention (Device): Diagnostic study, experimental evaluative cross-sectional study
- Lead sponsor: CARDIAGS
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)

## Provenance

Content hash: 53a039a4e53d538797085726ef8a1d76c1cebfd96eecce169bd1b2c24c4dad12
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
